Research Mucus clearance through High Frequency Chest Wall
Oscillation has been studied since 1983. The first human study was
published in 1989. Since then, in more than 50 studies, HFCWO has
consistently been shown to be a safe, effective and valuable tool
in the treatment of retained secretions. And the first cost comparison
study, detailing a 50% reduction in total healthcare costs with HFCWO,
was published by BlueCross in 1994.
|


